{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:01:41Z","timestamp":1787068901139,"version":"build-2736575974"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T00:00:00Z","timestamp":1643760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T00:00:00Z","timestamp":1643760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s00213-022-06080-1","type":"journal-article","created":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T04:04:01Z","timestamp":1643774641000},"page":"897-908","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Physiological dependence to mitragynine indicated by a rapid cross-dependence procedure with heroin-dependent mice"],"prefix":"10.1007","volume":"239","author":[{"given":"Kai","family":"Yue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1068-1159","authenticated-orcid":false,"given":"Jonathan L.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiji","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,2]]},"reference":[{"key":"6080_CR1","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1124\/jpet.109.152462","volume":"331","author":"JM Andersen","year":"2009","unstructured":"Andersen JM, Ripel A, Boix F, Normann PT, M\u00f8rland J (2009) Increased locomotor activity induced by heroin in mice: pharmacokinetic demonstration of heroin acting as a prodrug for the mediator 6-monoacetylmorphine in vivo. J Pharmacol Exp Ther 331:153\u2013161","journal-title":"J Pharmacol Exp Ther"},{"key":"6080_CR2","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jep.2010.03.036","volume":"129","author":"E Apryani","year":"2010","unstructured":"Apryani E, Hidayat MT, Moklas MAA, Fakurazi S, Idayu NF (2010) Effects of mitragynine from Mitragyna speciosa korth leaves on working memory. J Ethnopharmacol 129:357\u2013360","journal-title":"J Ethnopharmacol"},{"key":"6080_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-540-68706-1_940","volume-title":"Cross-dependence","author":"RL Balster","year":"2010","unstructured":"Balster RL, Walsh S (2010a) In: Stolerman IP (ed) Cross-dependence. Encyclopedia of Psychopharmacology. Springer, Berlin. https:\/\/doi.org\/10.1007\/978-3-540-68706-1_940"},{"key":"6080_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-540-68706-1_30","volume-title":"Encyclopedia of Psychopharmacology","author":"RL Balster","year":"2010","unstructured":"Balster RL, Walsh S (2010b) Abuse liability evaluation. In: Stolerman IP (ed) Encyclopedia of Psychopharmacology. Springer, Berlin. https:\/\/doi.org\/10.1007\/978-3-540-68706-1_30"},{"key":"6080_CR5","doi-asserted-by":"publisher","unstructured":"Bhowmik S, Galeta J, Havel V et al (2020) Site selective C-H functionalization of Mitragyna alkaloids reveals a molecular switch for tuning opioid receptor signaling efficacy. ChemRxiv. https:\/\/doi.org\/10.26434\/chemrxiv.12799787.v1","DOI":"10.26434\/chemrxiv.12799787.v1"},{"key":"6080_CR6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF00428791","volume":"33","author":"J Bl\u00e4sig","year":"1973","unstructured":"Bl\u00e4sig J, Herz A, Reinhold K, Zieglg\u00e4nsberger S (1973) Development of physical dependence on morphine in respect to time and dosage and quantification of the precipitated withdrawal syndrome in rats. Psychopharmacologia 33:19\u201338","journal-title":"Psychopharmacologia"},{"key":"6080_CR7","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1360-0443.2008.02209.x","volume":"103","author":"EW Boyer","year":"2008","unstructured":"Boyer EW, Babu KM, Adkins JE, McCurdy CR, Halpern JH (2008) Self-treatment of opioid withdrawal using kratom (Mitragyna speciosa korth). Addiction 103:1048\u20131050","journal-title":"Addiction"},{"key":"6080_CR8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.fitote.2015.12.001","volume":"109","author":"JM Carpenter","year":"2016","unstructured":"Carpenter JM, Criddle CA, Craig HK, Ali Z, Zhang ZH, Khan IA, Sufka KJ (2016) Comparative effects of Mitragyna speciosa extract, mitragynine, and opioid agonists on thermal nociception in rats. Fitoterapia 109:87\u201390","journal-title":"Fitoterapia"},{"key":"6080_CR9","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1021\/acs.biochem.0c00629","volume":"60","author":"S Chakraborty","year":"2021","unstructured":"Chakraborty S, Majumdar S (2021) Natural products for the treatment of pain: chemistry and pharmacology of salvinorin A, mitragynine, and collybolide. Biochemistry 60:1381\u20131400","journal-title":"Biochemistry"},{"key":"6080_CR10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jep.2017.07.008","volume":"208","author":"D Cheaha","year":"2017","unstructured":"Cheaha D, Reakkamnuan C, Nukitram J, Chittrakarn S, Phukpattaranont P, Keawpradub N, Kumarnsit E (2017) Effects of alkaloid-rich extract from Mitragyna speciosa (Korth.) Havil. on naloxone-precipitated morphine withdrawal symptoms and local field potential in the nucleus accumbens of mice. J Ethnopharmacol 208:129\u2013137","journal-title":"J Ethnopharmacol"},{"key":"6080_CR11","first-page":"189","volume":"182","author":"DL Cheney","year":"1972","unstructured":"Cheney DL, Judson BA, Goldstein A (1972) Failure of an opiate to protect mice against naloxone-precipitated withdrawal. J Pharmacol Exp Ther 182:189\u2013194","journal-title":"J Pharmacol Exp Ther"},{"key":"6080_CR12","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/237220a0","volume":"237","author":"HOJ Collier","year":"1972","unstructured":"Collier HOJ, Francis DL, Schneider C (1972) Modification of morphine withdrawal by drugs interacting with humoral mechanisms: some contradictions and their interpretation. Nature 237:220\u2013223","journal-title":"Nature"},{"key":"6080_CR13","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/0014-2999(81)90163-1","volume":"70","author":"J Dum","year":"1981","unstructured":"Dum J, Bl\u00e4sig J, Herz A (1981) Buprenorphine: demonstration of physical dependence liability. Eur J Pharmacol 70:293\u2013300. https:\/\/doi.org\/10.1016\/0014-2999(81)90163-1","journal-title":"Eur J Pharmacol"},{"key":"6080_CR14","doi-asserted-by":"publisher","first-page":"107946","DOI":"10.1016\/j.drugalcdep.2020.107946","volume":"209","author":"JD Foss","year":"2020","unstructured":"Foss JD, Nayak SU, Tallarida CS, Farkas DJ, Ward SJ, Rawls SM (2020) Mitragynine, bioactive alkaloid of kratom, reduces chemotherapy-induced neuropathic pain in rats through \u03b1-adrenoceptor mechanism. Drug and Alcohol Dependence 209:107946. https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.107946","journal-title":"Drug and Alcohol Dependence"},{"key":"6080_CR15","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1007\/s00213-015-3866-5","volume":"232","author":"N Harun","year":"2015","unstructured":"Harun N, Hassan Z, Navaratnam V, Mansor SM, Shoaib M (2015) Discriminative stimulus properties of mitragynine (kratom) in rats. Psychopharmacology (Berl) 232:2227\u20132238","journal-title":"Psychopharmacology (Berl)"},{"key":"6080_CR16","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00213-019-05418-6","volume":"237","author":"N Harun","year":"2020","unstructured":"Harun N, Johari IS, Mansor SM, Shoaib M (2020) Assessing physiological dependence and withdrawal potential of mitragynine using schedule-controlled behaviour in rats. Psychopharmacology (Berl) 237:855\u2013867","journal-title":"Psychopharmacology (Berl)"},{"key":"6080_CR17","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3389\/fpsyt.2020.00411","volume":"11","author":"R Hassan","year":"2020","unstructured":"Hassan R, Pike See C, Sreenivasan S, Mansor SM, M\u00fcller CP, Hassan Z (2020) Mitragynine attenuates morphine withdrawal effects in rats-a comparison with methadone and buprenorphine. Front Psychiatry 11:411","journal-title":"Front Psychiatry"},{"key":"6080_CR18","first-page":"239","volume":"67","author":"CK Himmelsbach","year":"1939","unstructured":"Himmelsbach CK (1939) Studies of certain addiction characteristics of (a) dihydromorphine (\u201cparamorphan\u201d), (b) dihydrodesoxymorphine-D (\u201cdesomorphine\u201d), (c) dihydrodesoxycodeine-D (\u201cdesocodeine\u201d), and (d) methyldihydromorphinone (\u201cmetopon\u201d). J Pharmacol Exp Ther 67:239\u2013249","journal-title":"J Pharmacol Exp Ther"},{"key":"6080_CR19","first-page":"17","volume":"77","author":"CK Himmelsbach","year":"1943","unstructured":"Himmelsbach CK, Andrews HL (1943) Studies on modification of the morphine abstinence syndrome by drugs. J Pharmacol Exp Ther 77:17\u201323","journal-title":"J Pharmacol Exp Ther"},{"key":"6080_CR20","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1124\/jpet.113.208264","volume":"348","author":"T Hiranita","year":"2014","unstructured":"Hiranita T, Kohut SJ, Soto PL, Tanda G, Kopajtic TA, Katz JL (2014) Preclinical efficacy of N-substituted benztropine analogs as antagonists of methamphetamine self-administration in rats. J Pharmacol Exp Ther 348:174\u2013191","journal-title":"J Pharmacol Exp Ther"},{"key":"6080_CR21","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0014-2999(91)90895-W","volume":"203","author":"P Horan","year":"1991","unstructured":"Horan P, Ho IK (1991) The physical dependence liability of butorphanol: a comparative study with morphine. Eur J Pharmacol 203:387\u2013391","journal-title":"Eur J Pharmacol"},{"key":"6080_CR22","first-page":"562","volume":"260","author":"CB Hubner","year":"1992","unstructured":"Hubner CB, Kornetsky C (1992) Heroin, 6-acetylmorphine and morphine effects on threshold for rewarding and aversive brain stimulation. J Pharmacol Exp Ther 260:562\u2013567","journal-title":"J Pharmacol Exp Ther"},{"key":"6080_CR23","first-page":"392","volume":"88","author":"JL Katz","year":"1986","unstructured":"Katz JL (1986) Effects of clonidine and morphine on opioid withdrawal in rhesus monkeys. Psychopharmacology (Berl) 88:392\u2013397","journal-title":"Psychopharmacology (Berl)"},{"key":"6080_CR24","doi-asserted-by":"publisher","unstructured":"Khor BS, Amar Jamil MF, Adenan MI, Chong Shu-Chien A (2011) Mitragynine attenuates withdrawal syndrome in\u00a0morphine-withdrawn zebrafish. PLoS One 6:e28340. https:\/\/doi.org\/10.1371\/journal.pone.0028340","DOI":"10.1371\/journal.pone.0028340"},{"key":"6080_CR25","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.neuropharm.2017.08.026","volume":"134","author":"AC Kruegel","year":"2018","unstructured":"Kruegel AC, Grundmann O (2018) The medicinal chemistry and neuropharmacology of kratom: a preliminary discussion of a promising medicinal plant and analysis of its potential for abuse. Neuropharmacology 134:108\u2013120","journal-title":"Neuropharmacology"},{"key":"6080_CR26","doi-asserted-by":"crossref","first-page":"6754","DOI":"10.1021\/jacs.6b00360","volume":"138","author":"AC Kruegel","year":"2016","unstructured":"Kruegel AC, Gassaway MM, Kapoor AK, V\u00e1radi A, Majumdar S, Filizola M, Javitch JA, Sames D (2016) Synthetic and receptor signaling explorations of the Mitragyna alkaloids: mitragynine as an atypical molecular framework for opioid receptor modulators. J Am Chem Soc 138:6754\u20136764","journal-title":"J Am Chem Soc"},{"key":"6080_CR27","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1021\/acscentsci.9b00141","volume":"5","author":"AC Kruegel","year":"2019","unstructured":"Kruegel AC, Uprety R, Grinnell SG, Langreck C, Pekarskaya EA, Le Rouzic V, Ansonoff M, Gassaway MM, Pintar JE, Pasternak GW, Javitch JA, Majumdar S, Sames D (2019) 7-Hydroxymitragynine is an active metabolite of mitragynine and a key mediator of its analgesic effects. ACS Cent Sci 5:992\u20131001","journal-title":"ACS Cent Sci"},{"key":"6080_CR28","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1213\/ANE.0000000000003662","volume":"129","author":"DY Liang","year":"2019","unstructured":"Liang DY, Li WW, Nwaneshiudu C, Irvine KA, Clark JD (2019) Pharmacological characters of oliceridine, a \u03bc-opioid receptor G-protein\u2013biased ligand in mice. Anesth Analg 129:1414\u20131421","journal-title":"Anesth Analg"},{"key":"6080_CR29","first-page":"69","volume":"279","author":"AH Lichtman","year":"1996","unstructured":"Lichtman AH, Meng Y, Martin BR (1996) Inhalation exposure to volatilized opioids produces antinociception in mice. J Pharmacol Exp Ther 279:69\u201376","journal-title":"J Pharmacol Exp Ther"},{"key":"6080_CR30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0091-3057(87)90545-4","volume":"26","author":"CW Loomis","year":"1987","unstructured":"Loomis CW, Milne B, Cervenko FW (1987) Determination of cross tolerance in rat spinal cord using intrathecal infusion via sequential mini-osmotic pumps. Pharmacol Biochem Behav 26:131\u2013139","journal-title":"Pharmacol Biochem Behav"},{"key":"6080_CR31","first-page":"145","volume":"198","author":"E Macko","year":"1972","unstructured":"Macko E, Weisbach JA, Douglas B (1972) Some observations on the pharmacology of mitragynine. Arch Int Pharmacodyn Ther 198:145\u2013161","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"6080_CR32","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1021\/acschemneuro.0c00141","volume":"11","author":"CA Madison","year":"2020","unstructured":"Madison CA, Arora M, Kumar MNVR, Eitan S (2020) Novel oral nanoparticle formulation of sustained release naloxone with mild withdrawal symptoms in mice. ACS Chem Neurosci 11:1955\u20131964","journal-title":"ACS Chem Neurosci"},{"key":"6080_CR33","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/0024-3205(96)00432-8","volume":"59","author":"K Matsumoto","year":"1996","unstructured":"Matsumoto K, Mizowaki M, Suchitra T, Takayama H, Sakai SI, Aimi N, Watanabe H (1996) Antinociceptive action of mitragynine in mice: evidence for the involvement of supraspinal opioid receptors. Life Sci 59:1149\u20131155","journal-title":"Life Sci"},{"key":"6080_CR34","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0091-3057(96)00314-0","volume":"57","author":"K Matsumoto","year":"1997","unstructured":"Matsumoto K, Mizowaki M, Takayama H, Sakai SI, Aimi N, Watanabe H (1997) Suppressive effect of mitragynine on the 5-methoxy-N,N-dimethyltryptamine-induced head-twitch response in mice. Pharmacol Biochem Behav 57:319\u2013323. https:\/\/doi.org\/10.1016\/S0091-3057(96)00314-0","journal-title":"Pharmacol Biochem Behav"},{"key":"6080_CR35","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1016\/j.lfs.2005.09.030","volume":"78","author":"K Matsumoto","year":"2006","unstructured":"Matsumoto K, Takayama H, Ishikawa H, Aimi N, Ponglux D, Watanabe K, Horie S (2006) Partial agonistic effect of 9-hydroxycorynantheidine on mu-opioid receptor in the guinea-pig ileum. Life Sci 78:2265\u20132271","journal-title":"Life Sci"},{"key":"6080_CR36","unstructured":"McCarthy DA (1959) Pharmacologic analysis of mechanism in the morphine-dependent state. Unpublished doctoral thesis, University of Michigan."},{"key":"6080_CR37","first-page":"21","volume":"4","author":"R Meepong","year":"2019","unstructured":"Meepong R, Sooksawate T (2019) Mitragynine reduced morphine-induced conditioned place preference and withdrawal in rodents. Thai J Pharmaceut Sci 4:21\u201329","journal-title":"Thai J Pharmaceut Sci"},{"key":"6080_CR38","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1021\/acs.jmedchem.9b01465","volume":"63","author":"S Obeng","year":"2019","unstructured":"Obeng S, Kamble SH, Reeves ME, Restrepo LF, Patel A, Behnke M et al (2019) Investigation of the adrenergic and opioid binding affinities, metabolic stability, plasma protein binding properties, and functional effects of selected indole-based kratom alkaloids. J Med Chem 63:433\u2013439","journal-title":"J Med Chem"},{"key":"6080_CR39","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1124\/jpet.120.000189","volume":"376","author":"S Obeng","year":"2021","unstructured":"Obeng S, Wilkerson JL, Le\u00f3n F, Reeves ME, Restrepo LF, Gamez-Jimenez LR, Patel A, Pennington AE, Taylor VA, Ho NP, Braun T (2021) Pharmacological comparison of mitragynine and 7-hydroxymitragynine: in vitro affinity and efficacy for \u03bc-opioid receptor and opioid-like behavioral effects in rats. J Pharmacol Exp Ther 376:410\u2013427. https:\/\/doi.org\/10.1124\/jpet.120.000189","journal-title":"J Pharmacol Exp Ther"},{"key":"6080_CR40","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF00421454","volume":"39","author":"A Oliverio","year":"1974","unstructured":"Oliverio A, Castellano C (1974) Genotype-dependent sensitivity and tolerance to morphine and heroin: dissociation between opiate-induced running and analgesia in the mouse. Psychopharmacologia 39:13\u201322","journal-title":"Psychopharmacologia"},{"key":"6080_CR41","first-page":"231","volume":"220","author":"AW Pircio","year":"1976","unstructured":"Pircio AW, Glyes JA, Cavanagh RL, Buyniski JP, Bieiwagen ME (1976) The pharmacology of butorphanol, a 3,14-dihydroxymorphinan narcotic antagonist analgesic. Arch Int Pharmacodyn Ther 220:231\u2013257","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"6080_CR42","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jep.2013.02.008","volume":"146","author":"A Sabetghadam","year":"2013","unstructured":"Sabetghadam A, Ramanathan S, Sasidharan S, Mansor SM (2013) Subchronic exposure to mitragynine, the principal alkaloid of Mitragyna speciosa, in rats. J Ethnopharmacol 146:815\u2013823","journal-title":"J Ethnopharmacol"},{"key":"6080_CR43","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.neulet.2008.05.103","volume":"440","author":"SD Schlussman","year":"2008","unstructured":"Schlussman SD, Zhang Y, Hsu NM, Allen JM, Ho A, Kreek MJ (2008) Heroin-induced locomotor activity and conditioned place preference in C57BL\/6J and 129P3\/J mice. Neurosci Lett 440:284\u2013288","journal-title":"Neurosci Lett"},{"key":"6080_CR44","first-page":"565","volume-title":"Volume I The Nervous System \u2014 Part A Central Nervous System Drugs","author":"MH Seevers","year":"1963","unstructured":"Seevers MH, Deneau GA (1963) Physiological aspects of tolerance and physical dependence. In: Root WS, Hofmann FG (eds) Volume I The Nervous System \u2014 Part A Central Nervous System Drugs. Academic Press, New York, pp 565\u2013640"},{"key":"6080_CR45","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jep.2018.12.038","volume":"233","author":"D Singh","year":"2019","unstructured":"Singh D, Narayanan S, M\u00fcller CP, Swogger MT, Chear NJY, Dzulkapli EB, Yusoff NSM, Ramachandram DS, Le\u00f3n F, McCurdy CR, Vicknasingam B (2019) Motives for using Kratom (Mitragyna speciosa Korth) among regular users in Malaysia. J Ethnopharmacol 233:34\u201340. https:\/\/doi.org\/10.1016\/j.jep.2018.12.038","journal-title":"J Ethnopharmacol"},{"key":"6080_CR46","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.drugalcdep.2017.08.034","volume":"180","author":"KE Smith","year":"2017","unstructured":"Smith KE, Lawson T (2017) Prevalence and motivations for kratom use in a sample of substance users enrolled in a residential treatment program. Drug Alcohol Depend 180:340\u2013348","journal-title":"Drug Alcohol Depend"},{"key":"6080_CR47","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jep.2013.10.059","volume":"151","author":"KJ Sufka","year":"2014","unstructured":"Sufka KJ, Loria MJ, Lewellyn K, Zjawiony JK, Ali Z, Abe N, Khan IA (2014) The effect of Salvia divinorum and Mitragyna speciosa extracts, fraction and major constituents on place aversion and place preference in rats. J Ethnopharmacol 151:361\u2013364","journal-title":"J Ethnopharmacol"},{"key":"6080_CR48","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0278-5846(83)90090-8","volume":"7","author":"T Suzuki","year":"1983","unstructured":"Suzuki T, Shimada M, Yoshii T, Yanaura UJ (1983) Development of physical dependence on and tolerance to morphine in rats treated with morphine-admixed food. Prog Neuropsychopharmacol Biol Psychiatry 7:63\u201371","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"6080_CR49","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0021-5198(19)52321-6","volume":"34","author":"T Suzuki","year":"1984","unstructured":"Suzuki T, Yoshii T, Yanaura S (1984) Induction of physical dependence on morphine in mice by the drug-admixed food method. Jpn J Pharmacol 34:319\u2013325","journal-title":"Jpn J Pharmacol"},{"key":"6080_CR50","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1016\/0024-3205(88)90250-0","volume":"42","author":"T Suzuki","year":"1988","unstructured":"Suzuki T, Fukagawa Y, Yoshii T, Yanaura S (1988) Effect of opioid agonist-antagonist interaction on morphine dependence in rats. Life Sci 42:2729\u20132737","journal-title":"Life Sci"},{"key":"6080_CR51","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/0024-3205(89)90125-2","volume":"45","author":"T Suzuki","year":"1989","unstructured":"Suzuki T, Fukagawa Y, Yoshii T, Yanaura S, Katz JL (1989) Modification of the effects of naloxone in morphine-dependent mice. Life Sci 45:1237\u20131246","journal-title":"Life Sci"},{"key":"6080_CR52","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1248\/cpb.52.916","volume":"52","author":"H Takayama","year":"2004","unstructured":"Takayama H (2004) Chemistry and pharmacology of analgesic indole alkaloids from the rubiaceous plant, Mitragyna speciosa. Chem Pharm Bull (Tokyo) 52:916\u2013928","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"6080_CR53","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1021\/jm010576e","volume":"45","author":"H Takayama","year":"2002","unstructured":"Takayama H, Ishikawa H, Kurihara M, Kitajima M, Aimi N, Ponglux D et al (2002) Studies on the synthesis and opioid agonistic activities of mitragynine-related indole alkaloids: discovery of opioid agonists structurally different from other opioid ligands. J Med Chem 45:1949\u20131956","journal-title":"J Med Chem"},{"key":"6080_CR54","first-page":"409","volume":"218","author":"JG Umans","year":"1981","unstructured":"Umans JG, Inturrisi CE (1981) Pharmacodynamics of subcutaneously administered diacetylmorphine, 6-acetylmorphine and morphine in mice. J Pharmacol Exp Ther 218:409\u2013415","journal-title":"J Pharmacol Exp Ther"},{"key":"6080_CR55","doi-asserted-by":"crossref","first-page":"8381","DOI":"10.1021\/acs.jmedchem.6b00748","volume":"59","author":"A V\u00e1radi","year":"2016","unstructured":"V\u00e1radi A, Marrone GF, Palmer TC, Narayan A, Szab\u00f3 MR, Le Rouzic V et al (2016) Mitragynine\/corynantheidine pseudoindoxyls as opioid analgesics with mu agonism and delta antagonism, which do not recruit \u03b2-arrestin-2. J Med Chem 59:8381\u20138397","journal-title":"J Med Chem"},{"key":"6080_CR56","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.drugpo.2009.12.003","volume":"21","author":"B Vicknasingam","year":"2010","unstructured":"Vicknasingam B, Narayanan S, Beng GT, Mansor SM (2010) The informal use of ketum (Mitragyna speciosa) for opioid withdrawal in the northern states of peninsular Malaysia and implications for drug substitution therapy. Int J Drug Policy 21:283\u2013288","journal-title":"Int J Drug Policy"},{"key":"6080_CR57","first-page":"73","volume-title":"Agonist and antagonist action of narcotic analgesic drugs","author":"JE Villarreal","year":"1973","unstructured":"Villarreal JE (1973) The effects of morphine agonists and antagonists on morphine-dependent rhesus monkeys. In: Kosterlitz HW, Collier HOJ, Villarreal JE (eds) Agonist and antagonist action of narcotic analgesic drugs. University Park Press, Baltimore, pp 73\u201393"},{"key":"6080_CR58","doi-asserted-by":"crossref","first-page":"108310","DOI":"10.1016\/j.drugalcdep.2020.108310","volume":"216","author":"LL Wilson","year":"2020","unstructured":"Wilson LL, Harris HM, Eans SO, Brice-Tutt AC, Cirino TJ, Stacy HM et al (2020) Lyophilized kratom tea as a therapeutic option for opioid dependence. Drug Alcohol Depend 216:108310","journal-title":"Drug Alcohol Depend"},{"key":"6080_CR59","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s10571-020-01034-7","volume":"41","author":"LL Wilson","year":"2021","unstructured":"Wilson LL, Chakraborty S, Eans SO, Cirino TJ, Stacy HM, Simons CA et al (2021) Kratom alkaloids, natural and semi-synthetic, show less physical dependence and ameliorate opioid withdrawal. Cell Mol Neurobiol 41:1131\u20131143","journal-title":"Cell Mol Neurobiol"},{"key":"6080_CR60","first-page":"43","volume":"34","author":"JH Woods","year":"1981","unstructured":"Woods JH, Katz JL, Young AM, Medzihradsky F, Smith CB (1981) Correlations among certain behavioral, physiological, and biochemical effects of narcotic agonists. NIDA Res Monogr 34:43\u201357","journal-title":"NIDA Res Monogr"},{"key":"6080_CR61","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/j.pain.0000000000001738","volume":"161","author":"MZ Wu","year":"2020","unstructured":"Wu MZ, Li ZH, Liang L, Ma PC, Cui D, Chen P, Wu GH, Song XJ (2020) Wnt signaling contributes to withdrawal symptoms from opioid receptor activation induced by morphine exposure or chronic inflammation. Pain 161:532\u2013544","journal-title":"Pain"},{"key":"6080_CR62","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF00432741","volume":"74","author":"AM Young","year":"1981","unstructured":"Young AM, Swain HH, Woods JH (1981) Comparison of opioid agonists in maintaining responding and in suppressing morphine withdrawal in rhesus monkeys. Psychopharmacology (Berl) 74:329\u2013335","journal-title":"Psychopharmacology (Berl)"},{"key":"6080_CR63","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1007\/s00213-018-4974-9","volume":"235","author":"K Yue","year":"2018","unstructured":"Yue K, Kopajtic TA, Katz JL (2018) Abuse liability of mitragynine assessed with a self-administration procedure in rats. Psychopharmacology (Berl) 235:2823\u20132829","journal-title":"Psychopharmacology (Berl)"},{"key":"6080_CR64","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/adb.12185","volume":"21","author":"NHM Yusoff","year":"2014","unstructured":"Yusoff NHM, Suhaimi FW, Vadivelu RK, Hassan Z, R\u00fcmler A, Rotter A, Amato D, Dringenberg HC, Mansor SM, Navaratnam V, M\u00fcller CP (2014) Abuse potential and adverse cognitive effects of mitragynine (kratom). Addict Biol 21:98\u2013110. https:\/\/doi.org\/10.1111\/adb.12185","journal-title":"Addict Biol"},{"key":"6080_CR65","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.drugalcdep.2018.08.002","volume":"192","author":"CA Zamarripa","year":"2018","unstructured":"Zamarripa CA, Edwards SR, Qureshi HN, John NY, Blough BE, Freeman KB (2018) The G-protein biased mu-opioid agonist, TRV130, produces reinforcing and antinociceptive effects that are comparable to oxycodone in rats. Drug Alcohol Depend 192:158\u2013162","journal-title":"Drug Alcohol Depend"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-022-06080-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-022-06080-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-022-06080-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T05:14:29Z","timestamp":1646198069000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-022-06080-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,2]]},"references-count":65,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["6080"],"URL":"https:\/\/doi.org\/10.1007\/s00213-022-06080-1","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,2]]},"assertion":[{"value":"3 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}